Eying The Drug Delivery Regulatory Landscape: The 'Must See' Watch List For 2026

Join Chief Editor Tom von Gunden as he engages drug delivery regulatory experts Rumi Young, John “Barr” Weiner, and Fran DeGrazio in a dynamic discussion of the current and near future regulatory landscape for drug and biologics delivery devices, systems, platforms, and combination products. In a “Look Back,” Tom will invite the panel to comment on occurrences of note in 2025 that impacted delivery product development and related regulatory pathways. 

In a “Look Forward,” Tom will ask each panelist to identify for group discussion a top candidate for the “Most Impactful” regulatory movement or consideration for 2026 and beyond. Panel commentary and audience interaction will likely reference specific standards and guidances, such as the QMSR, as well as review progress toward global regulatory harmonization for delivery devices and combination products.